419 related articles for article (PubMed ID: 31941783)
1. A Factor I-Like Activity Associated with Chikungunya Virus Contributes to Its Resistance to the Human Complement System.
Nag J; Mukesh RK; Suma SM; Kunnakkadan U; Kumar NA; Johnson JB
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941783
[TBL] [Abstract][Full Text] [Related]
2. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
[TBL] [Abstract][Full Text] [Related]
3. The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.
Johnson JB; Grant K; Parks GD
J Virol; 2009 Aug; 83(15):7602-11. PubMed ID: 19457998
[TBL] [Abstract][Full Text] [Related]
4. Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection.
Kishishita N; Takeda N; Anuegoonpipat A; Anantapreecha S
J Clin Microbiol; 2013 May; 51(5):1389-95. PubMed ID: 23408687
[TBL] [Abstract][Full Text] [Related]
5. A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.
Johnson JB; Borisevich V; Rockx B; Parks GD
J Virol; 2015 Jan; 89(2):989-98. PubMed ID: 25355897
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antibody response in patients with acute and chronic chikungunya virus disease.
Anfasa F; Lim SM; Fekken S; Wever R; Osterhaus ADME; Martina BEE
J Clin Virol; 2019 Aug; 117():68-72. PubMed ID: 31229935
[TBL] [Abstract][Full Text] [Related]
7. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
8. The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.
Matkovic R; Bernard E; Fontanel S; Eldin P; Chazal N; Hassan Hersi D; Merits A; Péloponèse JM; Briant L
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463980
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
[TBL] [Abstract][Full Text] [Related]
10. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
[TBL] [Abstract][Full Text] [Related]
11. P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages.
Nayak TK; Mamidi P; Sahoo SS; Kumar PS; Mahish C; Chatterjee S; Subudhi BB; Chattopadhyay S; Chattopadhyay S
Front Immunol; 2019; 10():786. PubMed ID: 31031770
[TBL] [Abstract][Full Text] [Related]
12. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
Issac TH; Tan EL; Chu JJ
J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
[TBL] [Abstract][Full Text] [Related]
14. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
Amdekar S; Parashar D; Alagarasu K
Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection.
Hiroki CH; Toller-Kawahisa JE; Fumagalli MJ; Colon DF; Figueiredo LTM; Fonseca BALD; Franca RFO; Cunha FQ
Front Immunol; 2019; 10():3108. PubMed ID: 32082301
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylated Cysteines in Chikungunya Virus nsP1 Are Critical for Targeting to Cholesterol-Rich Plasma Membrane Microdomains with Functional Consequences for Viral Genome Replication.
Bakhache W; Neyret A; Bernard E; Merits A; Briant L
J Virol; 2020 May; 94(10):. PubMed ID: 32132240
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.
Neupane B; Acharya D; Nazneen F; Gonzalez-Fernandez G; Flynt AS; Bai F
Front Immunol; 2020; 11():588382. PubMed ID: 33304351
[TBL] [Abstract][Full Text] [Related]
19. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of Chikungunya virus inhibition by monoclonal antibodies.
Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
